Terapi hormon maskulin: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
kTidak ada ringkasan suntingan |
|||
Baris 40:
;Sumber tersitasi
* {{cite journal|last=Humbree |first=W. C. |author2=et al. |ref={{harvid|Humbree, et al.|2017}} |date=2017 |title=Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline |journal=The Journal of Clinical Endocrinology & Metabolism |volume=102 |issue=11 |pages=3869–3903|doi=10.1210/jc.2017-01658}}
* {{cite book |author=UCSF Transgender Care, Department of Family and Community Medicine, University of California San Francisco |ref={{harvid|USCF Transgender Care|2016}}|title=Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People |editon=2 |editor1-last=Deutsch |editor1-first=M. B. |date=2016 |publisher=UCSF Transgender Care |url=https://transcare.ucsf.edu/guidelines}}
* {{cite book|ref={{harvid|WPATH|2011}}|title=Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People 7th Version |author=World Professional Association for Transgender Health |year=2011 |url=http://www.wpath.org/site_page.cfm?pk_association_webpage_menu=1351&pk_association_webpage=3926}}
| |||